About Kaymed Pharmaceuticals Private Limited
Data last updated:
Kaymed Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2015PTC286392. Its GSTIN is 09AAFCK9696Q1Z8 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹62 Lakh. It is led by directors Manoj Kumar Agrawal and Shubham Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mez & First Floor A – 83 Okhla Phase – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.53 Lakh, a growth of 106% compared to the previous year. For the same year it recorded a net profit of ₹1.47 Lakh (net margin 7.5%) and EBITDA of ₹1.47 Lakh (EBITDA margin 7.5%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 20% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kaymed. The company has 4 deals on record (2 rights issues, 1 secondary share transfer, 1 funding round), with disclosed funding of ₹24 Lakh; the latest was in October 2018.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kaymedpharma.com.
Company details
Contact details
Kaymed Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is kaymedpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressMez & First Floor A – 83 Okhla Phase – 2, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kaymed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Kaymed Pharmaceuticals operates one associated brand: kaymed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of pharmaceutical products | kaymedpharma.com |
Business activity
The main business activity of Kaymed Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Kaymed Pharmaceuticals Private Limited, buy the company report.
Financials of Kaymed Pharmaceuticals Private Limited
FY 2025 filings availableKaymed Pharmaceuticals Private Limited reported revenue of ₹19.53 Lakh (up 106% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 106% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 20%. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kaymed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kaymed Pharmaceuticals Private Limited
Kaymed Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Agrawal | Director | 13 Oct 2015 | 11 Years 0 Months | Current |
| Shubham Agarwal | Director | 13 Oct 2015 | 11 Years 0 Months | Current |
Auditor
Kaymed Pharmaceuticals Private Limited is audited by JAKHODIA AGARWAL & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAKHODIA AGARWAL & ASSOCIATES | FY 2020 | 015281C |
Shareholding
The shareholding of Kaymed Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Kaymed Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Kaymed Pharmaceuticals Private Limited has 4 deals on record (2 rights issues, 1 secondary share transfer, 1 funding round), with disclosed funding of ₹24 Lakh; the latest was in October 2018.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Rights issue | ₹12 Lakh | Investors: 4 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2017 | Rights issue | ₹16 Lakh | Investors: 4 individuals |
| Feb 2017 | Funding round | ₹24 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Kaymed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kaymed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kaymed Pharmaceuticals Private Limited has a workforce of 5 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Kaymed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCK9696Q1Z8 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kaymed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kaymed Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Manoj Kumar Agrawal was appointed as Director on 13 Oct 2015.
Frequently asked questions
Kaymed Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2015 (11+ years old) and is registered under CIN U51397DL2015PTC286392.
Kaymed Pharmaceuticals has 2 current directors:
- Manoj Kumar Agrawal - Director
- Shubham Agarwal - Director
The latest financial statements of Kaymed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Kaymed Pharmaceuticals is 09AAFCK9696Q1Z8, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Kaymed Pharmaceuticals is U51397DL2015PTC286392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kaymed Pharmaceuticals was incorporated on 13 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Kaymed Pharmaceuticals has 4 deals on record (2 rights issues, 1 secondary share transfer, 1 funding round), with disclosed funding of ₹24 Lakh; the latest was in October 2018.
Manoj Kumar Agrawal was appointed as Director on 13 Oct 2015. Shubham Agarwal was appointed as Director on 13 Oct 2015.
Kaymed Pharmaceuticals can be reached through the website kaymedpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Kaymed Pharmaceuticals is at Mez & First Floor A – 83 Okhla Phase – 2, New Delhi, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
